MolDX Draft LCDs – Noridian

The following 13 draft JFB MolDX Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 02102 (AK), 03102 (AZ), 02202 (ID), 03202 (MT), 03302 (ND), 02302 (OR), 03402 (SD), 03502 (UT), 02402 (WA) and 03602 (WY).

DL38380            MolDX: AlloSure® Cell-Free DNA Testing

DL38349            MolDX: Combinatorial Pharmacogenomics Limited Coverage

DL38341            MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk

                            Disease

DL37748            MolDX: DecisionDX – Melanoma

DL38333            MolDX: Erythrocyte Molecular Antigen Typing

DL38317            MolDX: Molecular Microscope® Diagnostic System for the Heart

DL37744            MolDX: Oncotype AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer

                            (MCRPC)

DL38337            MolDX: Pharmacogenomics Testing

DL38329            MolDX: Razor 14-Gene Lung Cancer Assay

DL38353            MolDX: Repeat Germline Testing

DL38325            MolDX: SelectMDx and Erythrocyte Antigen Typing

DL38345            MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer

DL38321            MolDX: Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection

Source: https://med.noridianmedicare.com/web/jfb/article-detail/-/view/10534/moldx-draft-lcds-published-for-review-and-comments